chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sick with covid/coronavirus for week and half; sick with covid/coronavirus for week and half; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP) for a sponsored program.  A 62 year-old male patient received COVID-19 Vaccine - Manufacturer Unknown, (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer: Unknown, Dose number: Unknown), for Covid-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "sick with covid/coronavirus for week and half". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive, notes: Sick with covid/coronavirus for week and half. The lot number for COVID-19 Vaccine - Manufacturer Unknown was not provided and will be requested during follow up.; Sender's Comments: Based on the available information a contributory role of BNT162B2 to the reported events COVID-19, Drug ineffective cannot be totally excluded as efficacy of a drug varies from individual to individual depending upon the immune status. As with any vaccine, vaccination with BNT162B2 may not protect all vaccine recipients, so the expectedness of covid-19 and drug ineffective is : expected. The case will be reassessed further upon receipt of additional information.
09/08/22 presents to ED for "dizziness". PMHx of "hypertension, hyperlipidemia, diabetes with peripheral neuropathy, hypothyroidism, rheumatoid arthritis, spinal stenosis"
Noted to have significant vaccine leakage on skin when I looked back at the video that I took.  The nurse wiped off the fluid from skin.  We were not notified at the time and now cannot determine how much vaccine patient received.  Best guess is 75% (maybe)
Sore throat, chills, fever.  The following morning, I couldn't breathe, felt like my throat was closing.  Went to hospital.
My eyes are noticeably more sensitive to sunlight and artificial light. I did not have this experience before my Moderna vaccine #2.
2 weeks after 2nd shot, daily headaches; Moderate fatigue from 16:00 until following morning; This is a spontaneous report from a non-contactable consumer, the patient. A male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 26Feb2021 at 15:00, as a single dose for COVID-19 immunisation. Medical history included autoimmune urticaria. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 02Feb2021 at 15:00 as a single dose for COVID-19 immunisation. On 15Mar2021 at 16:00, 2 weeks after the second shot, the patient experienced daily headaches and moderate fatigue until following morning. The patient did not receive any treatment for the events reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 2 weeks after 2nd shot, daily headaches and moderate fatigue from 16:00 until following morning were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Pain for 24-48 hours at injection site. Weakness, fatigue, and malaise for 24 hours.
Information has been received from a healthcare worker referring to unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored MMR II (lot # was reported as L028273, expiration date 28-JUL-2017; lot # L012479, expiration date 10-APR-2017; lot # L015279, expiration date 30-APR-2017; dose and route were unknown). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Left neck into face numbness/leg and foot numbness. Peripheral neuropathy after flu shot.
pt recv vax 17FEB98 1230PM & parent reported child recv DTAP immun in rt arm afternoon 17FEB98;next morning area below muscle became inc red, swollen, warm to touch, tender & devel fever;painful, very red, swollen, hot @ site;fever;
Administrator administered inadvertently Menactra which had an expiration date of 8-3-07 (03Aug07).  No adverse effect.  Was given a dose of expired vaccine.
Rash on face, upper chest, antecubital fossa, axilla, lasting one month. erythematous, peeling. started 4 days after vaccination, pruritic  no blistering or oral lesion, non constitutional symptoms.  no associated illness.  Still present at one month, though improving.  Patient strongly associates rash with vaccine.  I'm evaluating for drug induced lupus or allergy to glipizide. gave triamcinolone, referred to derm,
My father died due to your mRNA vaccination; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "My father died due to your mRNA vaccination". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: My father died due to your mRNA vaccination
Injection site is itching, red, and hard one week and one day after receding vaccine.
Left upper arm swollen, red and sore. Elevated temperature. Body aches noted within 24 hours of administration. Treatment: cool compress to swollen arm, Motrin for pain and Benadryl for itchiness.
This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling on his feet/legs/thighs), JOINT SWELLING (Swelling on ankles) and PAIN IN EXTREMITY (Sore arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swelling on his feet/legs/thighs), JOINT SWELLING (Swelling on ankles) and PAIN IN EXTREMITY (Sore arm). On 01-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, PERIPHERAL SWELLING (Swelling on his feet/legs/thighs) and JOINT SWELLING (Swelling on ankles) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     No concomitant medications provided. No treatment information provided.; Reporter's Comments: Based on the current available information which includes a strong  temporal association between the use of the product and the start date of the reported events, a causal relationship with the event cannot be excluded
I woke up with a quarter size rash at the injection site.  It has grown in size each day.  today 4/27/2021 it is as large as a grapefruit, is red, hot to the touch and itchy.  Other than that no other side effects
Injection site immediately felt severe itchy following injection but diminished after approx. 30-45 minutes.  I then felt fine until exactly 3:00 pm (approx. 3 hours following injection).  I stood up and immediately felt like passing out.  I had excruciating cramping throughout my legs and horrible joint pain in my knees.  By 3:30 I had hives covering my right hand- my hand was also very red and swollen and had severe itching/burning. By now I also had horrific joint and muscle pains all over my entire body and the leg cramping was even worse.  the hives responded well two doses of Benadryl and the muscle aches somewhat improved with rotation of ibuprofen and Tylenol.  By 5:00 am the following day, the joint and muscle pains were worse.  My entire body felt like it was on fire and I had excruciating pain in my throat.  It was difficult to speak or swallow and I could feel my throat swollen on the inside.  My neck was also slightly swollen and the lymph nodes on the left side of my neck were in horrific pain but not swollen.  I continued doses of Benadryl, ibuprofen and Tylenol all day and night and slept most of the time.  By Sunday Morning, my throat felt even worse and I had 100 degree fever and continued body aches and joint pain.  I was seen at a local urgent care who ran various tests (see below) that were negative and advised me to treat as if it were an allergic reaction and go to ER if I got any worse.  Fever and pain improved by Monday and by Tuesday I was able to return to work but with significant fatigue and continued pain in my legs.  I continued to improve throughout the week.  Now the following week I overall feel back to normal other than I have continued leg pain, esp. in my knees by the end of the day.
Pt recvd 4 doses of Engerix-B & did not respond;
After shot of vaccine I became very sick to my stomach and very lightheaded for 3 days. Bedridden for 3 days after vaccine. My energy level became 0 during that time.
The vaccine was reconstituted 2 hour before the patient arrived; Case reference number US-BN-2021-001642 is a spontaneous case report initially received from consumer on 22-Apr-2021, and concerns a patient of an unknown demographics.  The patient's medical history was not provided.  The patient's concomitant medication details were not provided.  On unknown date, the patient received therapy of RabaVert (Inactivated Rabies Virus Vaccine, Batch no. was not provided) at unknown dosage regimen for unknown indication.  The vaccine was reconstituted two hours before the patient arrived (Product storage error).  At the time of this report it was no known whether the patient developed any adverse event.  No further information was provided.; Reporter's Comments: Product storage error is listed by convention. Reportedly, the vaccine was reconstituted two hours before the patient arrived. Since the vaccine is to be used immediately after reconstitution that is considered to be product storage error. No adverse events were reported. Product administration error is not related to RabAvert, but to human action.; Sender's Comments: Product storage error is listed by convention. Reportedly, the vaccine was reconstituted two hours before the patient arrived. Since the vaccine is to be used immediately after reconstitution that is considered to be product storage error. No adverse events were reported. Product administration error is not related to RabAvert, but to human action.
REDNESS AND SWELLING AT INJECTION SITE   PAIN/ITCHING AT INJECTION SITE
Shingrix subcutaneously instead of IM; This non-serious case was reported by a other health professional via call center representative and described the occurrence of intramuscular formulation administered by other route in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number 2KK72, expiry date 17-JUN-2024) for prophylaxis.   On 29-JUN-2023, the patient received Shingrix (subcutaneous). On 29-JUN-2023, an unknown time after receiving Shingrix, the patient experienced intramuscular formulation administered by other route (Verbatim: Shingrix subcutaneously instead of IM). The outcome of the intramuscular formulation administered by other route was unknown.   Additional Information: GSK receipt date: 29-Jun-2023 No reactions were reported. The reporter consented to follow-up via email. The patient received Shingrix subcutaneously instead of intramuscular, led to intramuscular formulation administered by other route.
Been sleeping for almost 5 days, nauseous, muscle weakness and exhaustion, rapid onset sinus infection, migraine I can't get rid of, hot and cold  Migraine startig 4/14 as of 6 pm 4/15 not gone.
Tiredness (exhausted); sweating but no fever Average temp was between 95.7 and 96.; Aches in joints (toes, ankles, right rear right shoulder.; Very watery diarrhea; This is a spontaneous report from a contactable consumer (Patient). A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, lot number: ER8733), via unspecified route of administration, administered in left arm on 30Apr2021 at 04:30 PM (at the age of 52-years-old) as dose 2, single for COVID-19 immunization in Hospital. Medical history included right hemicolectomy 1.5 years ago but still have diarrhea, and ongoing burp. Patient had no known allergies. Concomitant medication(s) included omeprazole 20mg taken for burp, hydroxyzine 25mg, and citalopram 40mg; all from unknown start and stop date. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, lot number: EW0161), via unspecified route of administration, administered in left arm on 09Apr2021 at 02:30 PM as dose 1, single for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior vaccination. The patient did not receive any other vaccine within four weeks of vaccination. On 30Apr2021 at 10:00 PM (same day of vaccination), patient experienced tiredness (exhausted), sweating but no fever average temp was between 95.7 and 96, aches in joints (toes, ankles, right and rear right shoulder), and very watery diarrhea (patient had a shortened colon but not usually had diarrhea that bad). Therapeutic measures taken for events included Tylenol 500mg. The patient was not tested for COVID-19 post vaccination. The outcome of the events was recovering.   No follow up attempts are possible. No further information is expected.
From initial information received on 4/30/04 from a nurse practitioner regarding an adverse event occurring in the USA, it was reported that a 33 year old female patient received her first dose of IMOVAX RABIES from a pre-exposure series, lot number W1419, route and site of administration not reported, on 1/20/04. That same day, the patient experienced headache, nausea, vomiting, and muscle aches. Reportedly, the symptoms lasted four days. The patient also received her second dose of IMOVAX RABIES and a third dose of the vaccine on unspecified dates. The lot numbers and routes and sites of administration were not reported. Reportedly, she experienced the same symptoms after the second and third dose, which lasted two days after each immunization. The patient's recovery status was not reported. From additional information received on 10/08/04 from a health care professional, it was reported that several unsuccessful attempts have been made by phone and certified mail to contact the patient for additional information. Per the reporter, the patient's recovery status is unknown. No further information is anticipated, this case is considered closed.
Pt states that site became itchy after infection, then site turned red, swollen warm to touch.
Information has been received from a LPN concerning a male pt who was vaccinated with an IM dose of pneumococcal 23v polysaccharide vaccine 0.5mL/once. Subsequently, the pt had a localized reaction and developed redness, swelling and pain at the injection site. There were no diagnostic lab tests performed. There was no medical treatment required. It was noted that the nurse was not sure if this was the first or second dose of the vaccine.  Unspecified medical attention was sought. There was no product quality complaint involved. Follow up information from the office indicated the reporter requested a "cease follow up". No further information is requested.
Pt states large local swelling @ injection C/O fatigue, nervousness, irritability, and states face breaking out.
Fever of 101, body aches, chills, headache.  Fever for about 24 hours.  Other symptoms for about 48 hours.
Many initial side effects: fever, nausea, fatigue, etc, lasting several days. Three days after the shot a stabbing pain in my left abdomen started, and lasted for weeks.
was administrated with an expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 9-week-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 23yl4, expiry date 4th April 2022) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 6th April 2022, the patient received the 1st dose of Pediarix and Pediarix Pre-Filled Syringe Device. On 6th April 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient:  US2022062600   Additional Information: GSK Receipt Date: 07-Apr-2022 Reporter's Comments: The reporter stated that the patient was administrated with an expired dose of Pediarix. No adverse event was reported. The vaccine administration facility is the same as primary reporter. The reporter consented to follow-up. Additional Supportive Information: The patient was administrated with an expired dose of Pediarix, which led to expired vaccine used. This case had been linked to US2022062600, reported for same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022062600:Same patient
Diffuse pink macular papular rash 4 days after MMR/V given. Afebrile. Observation done. Self resolved after 5 days.
Noticed dizziness and vertigo after first vaccine that came and went. Less than four hours after second, high pitched sound, predominantly in left ear. Varies from annoying to pain in ear, especially later in the day and/or exposure to cold wind. Sensitive to noise.
started experiencing post vaccination encephalopathy; This spontaneous case was reported by a consumer and describes the occurrence of ENCEPHALOPATHY (started experiencing post vaccination encephalopathy) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ENCEPHALOPATHY (started experiencing post vaccination encephalopathy) (seriousness criterion medically significant). At the time of the report, ENCEPHALOPATHY (started experiencing post vaccination encephalopathy) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  Company Comment: This is a Spontaneous case reported by a consumer, concerning an adult male patient, with no medical history reported, who experienced the unexpected and serious (due to medically significant) event of Encephalopathy, which occurred after an unspecified dose of mRNA-1273.222 vaccine. Since no vaccination nor event dates were provided, temporal association and latency cannot be properly assessed. No information disclosed about diagnostic tests performed, clinical course or treatments received. The benefit-risk relationship of mRNA-1273.222 vaccine is not affected by this report.          Reporter did not allow further contact
Beside left arm hurt, whole body was aching, headache, sleeping about 36 hours, chill, a little high fever....
Fever, joint pain, headache, fatigue, body ache, now a rash that has almost wrapped around the arm and still having some shortness of breath and dizziness.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. There was no information about concurrent condition, medical history or concomitant medication. On 25-FEB-2016, the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # L042846 and expiry date 15-SEP-2017) (dosing details unspecified) which underwent specific temperature excursion of: Temperature: 47F, Time frame: 35 hours, Data logger: There was no previous temperature excursion. No adverse effects were reported. No Product Quality Complaint (PQC) was involved. This is one of the two reports received from the same reporter. Additional information has been requested.
Patient received an extra booster dose and did not meet eligibility criteria. There were no adverse reactions.
Soreness at injection site, warmth and lump feeling. Rash on upper left arm. See it described as "covid arm".
Pt c/o tingling to left arm and left leg, taken to observation room.  VS stable, no distress noted.  Assessed by NP, resting quietly, denies chest tightness.  Observed for more than 30mins.  Released w/ precautions but no signs of allergic rxn.  Pt stable and released from the vaccination site.
After the first injection, I noticed mild mouth tingling, but nothing else, did not report as it was so mild and it was more notable in retrospect.  A week after the first injection developed vertigo for the first time in my life.  This lasted about a week had mostly resolved when I got the second dose.  Immediately upon receiving the second dose I felt faint.  I went to the observation area and when the feeling got stronger, reported it.  My blood pressure was taken and although I always have normal blood pressure, it was extremely high - 195/100.  My heart was racing.  I was observed for longer because of this, and was asked to lie down.  The faint feeling and high blood pressure lasted 30 min, at which time it started to improve and was sent home.  I persisted in having bouts of feeling faint (but never fainting) in the days and weeks following, joined with shortness of breath which started the second day after the second injection. I also had the normal fever, aches and pains for 4 days.  It is now a month after the second injection, and while the faintness and vertigo are mostly gone,  I have persistent shortness of breath.  Prior to the vaccine I had an albuterol inhaler that I would use 1-5 times a year for allergies.  Almost never used it.  I began having to use it multiple times daily after the second dose of the vaccine.  I am not on a steroid inhaler.  I have never had shortness of breath like this before.  I was examined at the doctors office, not much can be seen that is wrong.   An allergist believes that I did not have an allergy because my blood pressure was high instead of low as in anaphylaxis.
I lost about a cubic inch of muscle, big indentation. No pain just atrophy. I researched and it looks like a side affect of the polio vaccine? Please drop me a note so I can have an answer.  Thanks!
Moderna COVID-10 Vaccine EUA.  Patient developed congestion, slight tightness in throat and a funny taste in mouth.  Vital signs stable. Feeling continued, administered famotidine and cetirizine HCl, monitored until symptoms resolved.